Recent Postings to

Worst Pills, Best Pills Newsletter Articles

  View the entire March 2019 issue in PDF format

  • Study Reveals Increased Risk of Bleeding, Stroke from Combined Use of Oral Blood Thinners and NSAIDs
    (March 2019)
    Millions of Americans take anticoagulants on a long-term basis to prevent the formation of potentially harmful clots. Learn why such patients should avoid using nonsteroidal anti-inflammatory drugs.
  • Caving To Industry, FDA Kills Proposed Safety Rule on Generic Drug Labeling
    (March 2019)
    In his editor’s column, Dr. Michael Carome laments the FDA’s troubling decision to withdraw a proposed rule that would have allowed generic drug companies to promptly update safety warnings in their product labels.
  • Potentially Dangerous Lithium Drug Interactions
    (March 2019)
    Read about the many prescription medications that can interact in dangerous ways with lithium, the drug of choice for treating bipolar disorder, also known as manic depression.
  • Drug-Induced Restless Legs Syndrome
    (March 2019)
    Restless legs syndrome is a common neurological movement and sensory disorder that affects 5 to 10 percent of the population. In this article, we identify some of the many drugs that can cause or worsen this disorder.
  • Review of the Synthetic Human Growth Hormone Drug Somatropin
    (March 2019)
    Somatropin was first approved by the FDA in 1987 for the treatment of short stature in children with growth hormone (GH) deficiency. Find out why we recommend not using somatropin in children with short stature who have normal GH levels; people who develop GH deficiency in adulthood; or in healthy individuals as an anti-aging agent, to improve athletic performance or for body-building.

  View the entire February 2019 issue in PDF format

  View the entire January 2019 issue in PDF format

  • Important Clopidogrel (PLAVIX) Drug Interactions
    (January 2019)
    Read about the many prescription and over-the-counter medications that can interact in dangerous ways with clopidogrel, a widely used anti-platelet drug.
  • Florida Clinic Brazenly Deceives Patients About a Cancer “Treatment”
    (January 2019)
    In his editor’s column, Dr. Michael Carome recounts how a Florida medical clinic deceived patients by falsifying scientific journal citations in its promotion of a now-illegal heart-toxic drug called cesium chloride for treatment of cancer.
  • FDA Warns About Serious Genital Infections With Newest Class of Diabetes Drugs
    (January 2019)
    Learn about a rare but potentially fatal bacterial infection in the area of the genitals that has been linked to the diabetes drugs known as sodium-glucose cotransporter-2 inhibitors, commonly called “flozins.”
  • New Study Links Statins to a Rare Autoimmune Muscle Disorder
    (January 2019)
    In this article, we review new research showing that statins are associated with a potentially disabling autoimmune muscle disorder known as idiopathic inflammatory myositis, a rare disorder that is distinct from the much more common type of muscle injury seen with statins.
  • Review of the Parkinson’s Disease Drug Apomorphine (APOKYN)
    (January 2019)
    Find out about the risks and benefits of apomorphine, an injectable medicine approved by the FDA for treatment of specific symptoms that occur in patients with advanced Parkinson’s disease.
  • Question & Answer
    (January 2019)
    In response to a reader’s question about our article “Metformin: First-Choice Drug for Type 2 Diabetes” in the August 2018 issue, we discuss the risk of diarrhea and other adverse gastrointestinal effects that may occur when taking metformin.

Additional Information from Public Citizen

Copyright © 2019 Public Citizen's Health Research Group. All rights reserved.